Clinical Characteristics and Outcomes of Patients Admitted in Cardiac Intensive Care Unit with Cardiogenic Shock: A

Konstantinos C Siaravas1, Aidonis Rammos2, Aris Bechlioulis2

  • 1First Department of Cardiology, University Hospital of Ioannina, 45110 Ioannina, Greece.

PubMed

Insights

Cardiogenic shock (CS) has high mortality, especially in advanced SCAI stages. Improved clinical pathways and registries are crucial for better patient outcomes in this critical condition.

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock (CS) is a severe condition characterized by inadequate tissue perfusion due to diminished cardiac output.
  • Despite advancements, CS continues to have a high mortality rate.

Purpose of the Study:

  • To investigate the clinical characteristics, management approaches, and patient outcomes of cardiogenic shock.
  • To analyze short-term and long-term mortality in CS patients.

Main Methods:

  • Prospective, single-center observational study of 70 patients (SCAI stages B-E) in a Cardiac Intensive Care Unit.
  • Data collected included demographics, clinical status, hemodynamics, echocardiography, and biochemistry.
  • Primary outcomes were in-hospital, 1-month, and 1-year mortality; secondary outcomes included mechanical circulatory support (MCS), mechanical ventilation (MV), and continuous renal replacement therapy (CRRT) use.

Main Results:

  • Acute myocardial infarction-related CS (AMI-CS) and heart failure-related CS (HF-CS) comprised 64% of cases.
  • Overall in-hospital mortality was 49%.
  • Higher SCAI stage (C vs. B) independently predicted increased mortality. Elevated lactate, creatinine, and reduced cardiac output were key mortality predictors. IABP use was more common in AMI-CS.

Conclusions:

  • Cardiogenic shock is associated with a poor prognosis, particularly in patients with higher SCAI stages.
  • There is an urgent need for standardized clinical pathways and national registries to guide evidence-based care for CS.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
665
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
296
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
470
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
215
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.6K